|
|
|
Date: |
|
Aug 06, 2012
|
|
News Title: |
|
Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors
|
|
Source: |
|
H. Lee Moffitt Cancer Center & Research Institute
|
|
City: |
|
/
|
|
Country: |
|
United States
|
|
Categories: |
|
Drug Discovery
|
|
News Profile: |
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II,......> full story
|